Pharm-话题@MedSci

#Pharm#

730篇内容 | 2606人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1787530, encodeId=ea691e87530ce, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=GW Pharma的大麻二酚活性药物Epidiolex即将在美国上市, objectType=article, longId=149981, objectId=ec3b14998109, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec3b14998109, replyNumber=0, likeNumber=62, createdTime=2019-07-23, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec3b14998109, moduleTitle=GW Pharma的大麻二酚活性药物Epidiolex即将在美国上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec3b14998109)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787549, encodeId=7f101e875499d, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Pharmacotherapy：前列腺癌患者雄激素剥夺治疗相关的主要长期副作用有哪些？, objectType=article, longId=154369, objectId=4bff154369ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bff154369ef, replyNumber=0, likeNumber=102, createdTime=2019-08-08, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bff154369ef, moduleTitle=Pharmacotherapy：前列腺癌患者雄激素剥夺治疗相关的主要长期副作用有哪些？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bff154369ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787591, encodeId=5d501e8759181, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Bexion Pharmaceuticals宣布开展I期试验的第3部分以评价BXQ-350治疗癌症的可行性, objectType=article, longId=161122, objectId=d5d316112204, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5d316112204, replyNumber=0, likeNumber=60, createdTime=2019-12-21, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5d316112204, moduleTitle=Bexion Pharmaceuticals宣布开展I期试验的第3部分以评价BXQ-350治疗癌症的可行性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5d316112204)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787506, encodeId=29761e87506a3, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Biomed Pharmacother：血管生成素2促进组织工程骨中的血管生成，并通过诱导自噬改善骨缺损的修复, objectType=article, longId=144883, objectId=e3811448835f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3811448835f, replyNumber=0, likeNumber=67, createdTime=2019-07-04, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3811448835f, moduleTitle=Biomed Pharmacother：血管生成素2促进组织工程骨中的血管生成，并通过诱导自噬改善骨缺损的修复, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3811448835f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787503, encodeId=17231e875037a, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Biomed Pharmacother：研究提供了结肠癌新的治疗靶点, objectType=article, longId=142176, objectId=2c041421e632, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c041421e632, replyNumber=0, likeNumber=80, createdTime=2019-02-10, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c041421e632, moduleTitle=Biomed Pharmacother：研究提供了结肠癌新的治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c041421e632)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787590, encodeId=6e111e87590f8, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=2019年美国皮肤病学会会议：Principia Biopharma将宣布疱疮寻常型试验的全新数据, objectType=article, longId=161013, objectId=3a4b1610135a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a4b1610135a, replyNumber=0, likeNumber=54, createdTime=2019-04-20, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a4b1610135a, moduleTitle=2019年美国皮肤病学会会议：Principia Biopharma将宣布疱疮寻常型试验的全新数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a4b1610135a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787490, encodeId=ca8f1e874907e, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Int J Pharm：富含血小板的血浆纳入同轴电纺纳米纤维可用于骨组织工程, objectType=article, longId=141373, objectId=69081413e3d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69081413e3d5, replyNumber=0, likeNumber=72, createdTime=2019-03-28, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69081413e3d5, moduleTitle=Int J Pharm：富含血小板的血浆纳入同轴电纺纳米纤维可用于骨组织工程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69081413e3d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787553, encodeId=4aba1e87553f0, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Ann Pharmacother：COPD急性加重：全身性糖皮质激素要联合ICS吗？, objectType=article, longId=155422, objectId=33b21554225d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33b21554225d, replyNumber=0, likeNumber=68, createdTime=2019-02-10, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33b21554225d, moduleTitle=Ann Pharmacother：COPD急性加重：全身性糖皮质激素要联合ICS吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33b21554225d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787543, encodeId=6d641e8754359, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Iran J Pharm Res：甘草乙酸乙酯提取物增强人骨髓间充质干细胞的增殖和成骨分化, objectType=article, longId=153185, objectId=dc951531853c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc951531853c, replyNumber=0, likeNumber=47, createdTime=2018-11-19, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc951531853c, moduleTitle=Iran J Pharm Res：甘草乙酸乙酯提取物增强人骨髓间充质干细胞的增殖和成骨分化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc951531853c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787528, encodeId=f1bd1e8752801, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Ferring Pharmaceuticals在英国推出睾酮替代疗法Testavan治疗性腺功能减退, objectType=article, longId=149625, objectId=38d4149625b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38d4149625b6, replyNumber=0, likeNumber=56, createdTime=2019-05-28, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38d4149625b6, moduleTitle=Ferring Pharmaceuticals在英国推出睾酮替代疗法Testavan治疗性腺功能减退, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38d4149625b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787525, encodeId=6ea11e8752548, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=J Ocul Pharmacol Ther：2％多佐胺和0.5％噻吗洛尔（COSOPT）冷藏使用比常温使用具有较少的眼部不适, objectType=article, longId=149403, objectId=5d0f149403e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d0f149403e6, replyNumber=0, likeNumber=80, createdTime=2019-03-01, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d0f149403e6, moduleTitle=J Ocul Pharmacol Ther：2％多佐胺和0.5％噻吗洛尔（COSOPT）冷藏使用比常温使用具有较少的眼部不适, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d0f149403e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787496, encodeId=d53e1e8749616, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Pharmacotherapy：心衰伴射血分数降低使用沙库巴曲缬沙坦or卡托普利更划算？, objectType=article, longId=141968, objectId=8ab4141968fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ab4141968fd, replyNumber=0, likeNumber=80, createdTime=2019-02-18, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ab4141968fd, moduleTitle=Pharmacotherapy：心衰伴射血分数降低使用沙库巴曲缬沙坦or卡托普利更划算？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ab4141968fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787472, encodeId=9b571e87472e9, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Front Pharmacol：研究揭示异柠檬酸内酯C在葡萄膜炎和视网膜炎性疾病中的治疗作用机制, objectType=article, longId=138307, objectId=b26713830e7a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b26713830e7a, replyNumber=0, likeNumber=97, createdTime=2018-07-14, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b26713830e7a, moduleTitle=Front Pharmacol：研究揭示异柠檬酸内酯C在葡萄膜炎和视网膜炎性疾病中的治疗作用机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b26713830e7a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787571, encodeId=5ea01e87571d5, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Ann Pharmacother：心脏手术患者围手术期镇静：基于右美托咪定vs基于丙泊酚方案, objectType=article, longId=157467, objectId=12e215e467ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12e215e467ff, replyNumber=0, likeNumber=72, createdTime=2019-02-28, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12e215e467ff, moduleTitle=Ann Pharmacother：心脏手术患者围手术期镇静：基于右美托咪定vs基于丙泊酚方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12e215e467ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787575, encodeId=70971e875752b, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=FDA批准MGB Biopharma的新型抗生素IND申请治疗艰难梭菌相关性腹泻, objectType=article, longId=158875, objectId=0f461588e508, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f461588e508, replyNumber=0, likeNumber=60, createdTime=2019-03-30, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f461588e508, moduleTitle=FDA批准MGB Biopharma的新型抗生素IND申请治疗艰难梭菌相关性腹泻, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f461588e508)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787493, encodeId=ad861e8749372, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Pharmacotherapy：MI后再灌注标准治疗β受体阻滞剂受质疑！, objectType=article, longId=141676, objectId=ab751416e6bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab751416e6bd, replyNumber=0, likeNumber=91, createdTime=2019-05-17, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab751416e6bd, moduleTitle=Pharmacotherapy：MI后再灌注标准治疗β受体阻滞剂受质疑！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab751416e6bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787484, encodeId=692a1e87484a0, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Eur J Pharmacol：Bcl-2抑制剂ABT-737在过敏性鼻炎模型中的抗过敏性和抗炎症作用研究, objectType=article, longId=140910, objectId=2bdb14091076, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bdb14091076, replyNumber=0, likeNumber=64, createdTime=2018-08-05, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bdb14091076, moduleTitle=Eur J Pharmacol：Bcl-2抑制剂ABT-737在过敏性鼻炎模型中的抗过敏性和抗炎症作用研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2bdb14091076)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787515, encodeId=a17d1e87515e9, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=A1M Pharma的候选药物ROSgard临床前研究显示出对急性肾损伤的强大保护作用, objectType=article, longId=146436, objectId=3dfe14643669, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dfe14643669, replyNumber=0, likeNumber=54, createdTime=2019-04-29, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dfe14643669, moduleTitle=A1M Pharma的候选药物ROSgard临床前研究显示出对急性肾损伤的强大保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3dfe14643669)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787552, encodeId=4e4f1e8755205, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Eur Rev Med Pharmacol Sci：血清炎症标志物与糖尿病视网膜病变的关联-文献综述, objectType=article, longId=154908, objectId=6a41154908a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a41154908a7, replyNumber=0, likeNumber=111, createdTime=2019-11-08, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a41154908a7, moduleTitle=Eur Rev Med Pharmacol Sci：血清炎症标志物与糖尿病视网膜病变的关联-文献综述, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a41154908a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1787539, encodeId=b9e61e8753974, content=<a href='/topic/show?id=fa03141591e' target=_blank style='color:#2F92EE;'>#Pharm#</a>, objectTitle=Pharmacoeconomics：PCSK9抑制剂具成本效果吗？, objectType=article, longId=151158, objectId=8d97151158a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d97151158a5, replyNumber=0, likeNumber=47, createdTime=2018-12-14, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d97151158a5, moduleTitle=Pharmacoeconomics：PCSK9抑制剂具成本效果吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d97151158a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Pharm

2020-05-29

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

GW Pharma的大麻二酚活性药物Epidiolex即将在美国上市

2019-07-23

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Pharmacotherapy：前列腺癌患者雄激素剥夺治疗相关的主要长期副作用有哪些？

2019-08-08

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Bexion Pharmaceuticals宣布开展I期试验的第3部分以评价BXQ-350治疗癌症的可行性

2019-12-21

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Biomed Pharmacother：血管生成素2促进组织工程骨中的血管生成，并通过诱导自噬改善骨缺损的修复

2019-07-04

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Biomed Pharmacother：研究提供了结肠癌新的治疗靶点

2019-02-10

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

2019年美国皮肤病学会会议：Principia Biopharma将宣布疱疮寻常型试验的全新数据

2019-04-20

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Int J Pharm：富含血小板的血浆纳入同轴电纺纳米纤维可用于骨组织工程

2019-03-28

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Ann Pharmacother：COPD急性加重：全身性糖皮质激素要联合ICS吗？

2019-02-10

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Iran J Pharm Res：甘草乙酸乙酯提取物增强人骨髓间充质干细胞的增殖和成骨分化

2018-11-19

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Ferring Pharmaceuticals在英国推出睾酮替代疗法Testavan治疗性腺功能减退

2019-05-28

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

J Ocul Pharmacol Ther：2％多佐胺和0.5％噻吗洛尔（COSOPT）冷藏使用比常温使用具有较少的眼部不适

2019-03-01

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Pharmacotherapy：心衰伴射血分数降低使用沙库巴曲缬沙坦or卡托普利更划算？

2019-02-18

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Front Pharmacol：研究揭示异柠檬酸内酯C在葡萄膜炎和视网膜炎性疾病中的治疗作用机制

2018-07-14

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Ann Pharmacother：心脏手术患者围手术期镇静：基于右美托咪定vs基于丙泊酚方案

2019-02-28

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

FDA批准MGB Biopharma的新型抗生素IND申请治疗艰难梭菌相关性腹泻

2019-03-30

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Pharmacotherapy：MI后再灌注标准治疗β受体阻滞剂受质疑！

2019-05-17

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Eur J Pharmacol：Bcl-2抑制剂ABT-737在过敏性鼻炎模型中的抗过敏性和抗炎症作用研究

2018-08-05

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

A1M Pharma的候选药物ROSgard临床前研究显示出对急性肾损伤的强大保护作用

2019-04-29

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Eur Rev Med Pharmacol Sci：血清炎症标志物与糖尿病视网膜病变的关联-文献综述

2019-11-08

jj000001 (审核中...)

前往app查看评论内容

#Pharm#

Pharmacoeconomics：PCSK9抑制剂具成本效果吗？

2018-12-14

科室
- - 订阅+
  - 更多科室
工具
服务